Ozempic, known generically as semaglutide, was approved by the FDA in December 2017 for the treatment of type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking a natural hormone in the body that targets areas of the brain that regulate appetite and food intake.

Still, you turn the dial each week. Click. Another small surrender. Another small salvation. The sound no longer promises transformation. It just promises next —next dose, next week, next version of yourself you’re still learning to recognize.

The "Ozempic click" is a key feature of the Ozempic dosing experience, designed to ensure that patients with type 2 diabetes can easily and accurately administer their medication. As the medication continues to be used for both diabetes management and weight loss, understanding its administration, including the reassuring sound of the "Ozempic click," remains important for both patients and healthcare providers.